Barrier-method contraceptives and pelvic inflammatory disease. JAMA 1982 Jul 09;248(2):184-7
Date
07/09/1982Pubmed ID
7087109Scopus ID
2-s2.0-0019940129 (requires institutional sign-in at Scopus site) 107 CitationsAbstract
The protective effect of barrier-method contraception against pelvic inflammatory disease (PID) was examined by analyzing data from the Women's Health Study, a large multicenter case-control study. We compared the contraceptive methods used by 645 women hospitalized for initial episodes of PID with the contraceptive methods used by 2,509 control subjects reporting no history of PID. The risk of hospitalization for PID in women currently using barrier methods relative to women using all other methods and to women using no method of contraception was 0.6 (95% confidence limits, 0.5 to 0.9) for both comparisons. This protective effect was observed for both chemical and mechanical barrier methods, although it was not statistically significant for the former. The prevention of PID and its sequelae is one of the most important noncontraceptive benefits of barrier methods of contraception.
Author List
Kelaghan J, Rubin GL, Ory HW, Layde PMAuthor
Peter M. Layde MS, MD Emeritus Professor in the Emergency Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdolescentAdult
Contraceptive Devices, Female
Contraceptive Devices, Male
Female
Humans
Intrauterine Devices
Methods
Pelvic Inflammatory Disease
Risk
Spermatocidal Agents
